Recruiting

Observational Study

Sponsor:

PerCuro Clinical Research Ltd

Code:

NCT00984711

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 19+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

This study was designed to gather data regarding the efficacy and safety of Rituxan in clinical practice whereby patients may present with concomitant medical conditions, medications as well as varying presentations of rheumatoid arthritis not always captured within the "purer" population seen in an industry sponsored clinical trial.

Conditions

Rheumatoid Arthritis

Study ID

NCT00984711

Start date

May, 2007

Status verified date

Sep, 2010

Completion date

Dec, 2015

Anticipated

Primary completion date

May, 2015

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 19+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Subjects with active rheumatoid arthritis as defined by ACR criteria
  • > 18 years of age at time of consent
  • Able to start RITUXAN therapy per the approved product monograph within approximately 30 days of confirmed enrollment

Exclusion Criteria:

  • Known Type 1 hypersensitivity or anaphylactic reactions to murine proteins, Chinese Hamster Ovary cell proteins or to any component of RITXAN as per approved Product monograph
  • Presence of any significant and or uncontrolled medical condition, which in the Investigator's opinion, precludes the use of RITUXAN as outlined in the Product Monograph

Study Design

Enrollment

150 participants

Anticipated

Interventions and Outcome Measures

Central Contacts and Locations

Central contacts

Leeanna Bulinckx, RN, BScN

250-382-6270

Chantal Vaillancourt, RN, BScN

250-382-6270

Locations

PerCuro Clinical Research Ltd.

Recruiting

Victoria, British Columbia, Canada, V8V 3P9

Principal Investigator:

Christopher J Atkins, MD

More Information

Sponsor

PerCuro Clinical Research Ltd

Last update posted

Sep 24, 2010

Last verified

Sep, 2010

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by PerCuro Clinical Research Ltd on 2010-09-24.